KMTS (Kestra Medical Technologies, Ltd. Common Stock)
Insider Trading Activity
Every open-market purchase and sale reported by KMTS officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-18 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-08-11 | Vaseem Mahboob | Chief Financial Officer | Sell | — | — |
| 2026-08-06 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-08-06 | Vaseem Mahboob | Chief Financial Officer | Sell | — | — |
| 2026-08-06 | Traci S Umberger | See Remarks | Sell | — | — |
| 2026-08-06 | Alfred J Ford Jr | Chief Commercial Officer | Sell | — | — |
| 2026-08-06 | Vaseem Mahboob | Chief Financial Officer | Sell | — | — |
| 2026-08-06 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-08-06 | Traci S Umberger | See Remarks | Sell | — | — |
| 2026-08-06 | Alfred J Ford Jr | Chief Commercial Officer | Sell | — | — |
| 2026-08-03 | Traci S Umberger | See Remarks | Sell | — | — |
| 2026-08-03 | Alfred J Ford Jr | Chief Commercial Officer | Sell | — | — |
| 2026-08-03 | Vaseem Mahboob | Chief Financial Officer | Sell | — | — |
| 2026-08-03 | Timothy P. Moran | Chief Business Officer | Sell | — | — |
| 2026-08-03 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-07-17 | Traci S Umberger | See Remarks | A | — | — |
| 2026-07-17 | Alfred J Ford Jr | Chief Commercial Officer | A | — | — |
| 2026-07-17 | Vaseem Mahboob | Chief Financial Officer | A | — | — |
| 2026-07-17 | Timothy P. Moran | Chief Business Officer | A | — | — |
| 2026-07-17 | Brian Daniel Webster | See Remarks | MIXED | — | — |
| 2026-07-02 | Timothy P. Moran | Chief Business Officer | A | — | — |
| 2026-07-02 | Traci S Umberger | See Remarks | A | — | — |
| 2026-06-17 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-06-04 | Brian Daniel Webster | See Remarks | A | — | — |
| 2026-06-04 | Traci S Umberger | See Remarks | A | — | — |
| 2026-06-04 | Timothy P. Moran | Chief Business Officer | A | — | — |
| 2026-06-04 | Alfred J Ford Jr | Chief Commercial Officer | A | — | — |
| 2026-06-04 | Vaseem Mahboob | Chief Financial Officer | A | — | — |
| 2026-05-18 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-04-16 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-03-30 | RAYMOND W COHEN | Director | Buy | — | — |
| 2026-03-19 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-03-12 | Kevin C Reilly | Director | A | — | — |
| 2026-02-19 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2026-01-20 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2025-12-31 | Brian Daniel Webster | See Remarks | Sell | — | — |
| 2025-12-31 | Traci S Umberger | See Remarks | Sell | — | — |
| 2025-12-04 | Timothy P. Moran | Chief Business Officer | A | — | — |
| 2025-09-15 | Traci S Umberger | See Remarks | Buy | — | — |
| 2025-09-15 | Alfred J Ford Jr | Chief Commercial Officer | Buy | — | — |
| 2025-09-08 | Conor Hanley | Director | A | — | — |
| 2025-09-08 | Mary Kay Ladone | Director | A | — | — |
| 2025-09-08 | RAYMOND W COHEN | Director | MIXED | — | — |
| 2025-09-08 | Elizabeth Kwo | Director | A | — | — |
| 2025-09-08 | Jeffrey Lawrence Schwartz | Director | A | — | — |
| 2025-07-24 | RAYMOND W COHEN | Director | A | — | — |
| 2025-07-21 | Alfred J Ford Jr | Chief Commercial Officer | A | — | — |
| 2025-07-21 | Brian Daniel Webster | See Remarks | A | — | — |
| 2025-07-21 | Vaseem Mahboob | Chief Financial Officer | A | — | — |
| 2025-07-21 | Traci S Umberger | See Remarks | A | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | Director | 27,030,134 | — |
| — | See Remarks | 460,215 | — |
| — | See Remarks | 195,825 | — |
| — | Chief Commercial Officer | 99,564 | — |
| — | Chief Business Officer | 68,725 | — |
| — | Chief Financial Officer | 60,609 | — |
| — | Director | 50,903 | — |
| — | Director | 23,903 | — |
| — | Director | 13,120 | — |
| — | Director | 10,909 | — |
| — | Director | 8,300 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the KMTS quote page; the site-wide leaderboard is on the insider transactions hub.